Table 3. Western blotting results for FMRP, GABRθ, mGluR5 and GABRρ2 values expressed as ratios to β-actin and neuronal-specific enolase (NSE) in lateral cerebellum.

	ANOVA		Control		Schizophrenia		Bipolar disorder		Major depression
	F	P	Protein	P	Protein	P	Protein	P	Protein	P
GABRθ/β-actin	5.49	0.003	0.425±0.105	RG	0.231±0.136	0.001	0.297±0.090	0.012	0.301±0.138	0.014
GABRρ2/β-actin	2.90	0.047	0.023±0.013	RG	0.048±0.042	NC	0.047±0.014	0.0044	0.058±0.038	0.0085
mGluR5 dimer/β-actin	2.14	NC	0.176±0.111	RG	0.125±0.10	NC	0.127±0.101	NC	0.211±0.064	NC
mGluR5 monomer/β-actin	4.15	0.011	0.038±0.030	RG	0.015±0.023	0.05	0.0086±0.0098	0.001	0.019±0.020	NC
FMRP/β-actina	6.22	0.001	0.070±0.052	RG	0.017±0.029	0.039	0.029±0.033	0.014	0.023±0.021	0.005
β-actin	0.83	NC	25.8±2.07	RG	25.2±2.07	NC	26.9±2.91	NC	26.1±4.38	NC
GABRθ/NSE	5.61	0.002	0.87±0.18	RG	0.48±0.30	0.001	0.58±0.20	0.005	0.62±0.24	0.012
GABRρ2/NSE	3.05	0.039	0.045±0.025	RG	0.1±0.094	NC	0.096±0.052	0.009	0.13±0.085	0.006
mGluR5 dimer/NSE	1.99	NC	0.32±0.20	RG	0.26±0.23	NC	0.26±0.22	NC	0.44±0.12	NC
mGluR5 monomer/NSE	5.18	0.004	0.08±0.48	RG	0.032±0.049	0.03	0.017±0.021	0.004	0.041±0.041	0.047
FMRP/NSE	4.93	0.004	0.092±0.07	RG	0.023±0.04	0.001	0.042±0.05	0.003	0.033±0.033	0.001
NSE	0.93	NC	20.2±3.34	RG	20.1±1.67	NC	20.2±3.24	NC	21.6±2.87	NC

Abbreviations: ANOVA, analysis of variance; NC, no change; RG, reference group.

^aFMRP data reprinted from Schizophrenia Research, 124(1–3):246-247, Fatemi, S.H., Kneeland, R.E., Liesch, S.B., Folsom, T.D., Fragile X mental retardation protein levels are decreased in major psychiatric disorders, page 246, Copyright (2010), with permission from Elsevier.

Bold values indicate significant (P<0.05) values.